• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • David Bishop, UK

    David Bishop, UK

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Frank Taylor, USA

    Frank Taylor, USA

  • Ali Var, Turkey

    Ali Var, Turkey

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Michael Lee, Australia

    Michael Lee, Australia

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Luis Antonio Pimenta Lima, Brazil

    Luis Antonio Pimenta Lima, Brazil

  • Philip Brindle, England

    Philip Brindle, England

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Susan Keldani, USA

    Susan Keldani, USA

  • Mark Miller, UK

    Mark Miller, UK

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Jason Goodman, USA

    Jason Goodman, USA

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login